Clinical Trial: RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis Complex and Sporadic Lymphangioleiomyomatosis

Brief Summary:

The purpose of this research study is to find out what effects RAD001 has on angiomyolipomas of a person with Tuberous Sclerosis Complex and to determine the safe dose of RAD001 without toxicity.

The hypothesis is that the drug will inhibit the growth of the angiomyolipomas and possibly even cause regression.